Top

Published in:

01-04-2022 | Adrenalectomy | Original Article

A combination of laparoscopic approach and ERAS pathway optimizes outcomes and cost for adrenalectomy

Authors: Zhiwen He, Siming Chen, Mengxin Lu, Yongwen Luo, Tongzu Liu, Yu Xiao, Xinghuan Wang

Published in: Updates in Surgery | Issue 2/2022

Abstract

Enhanced recovery after surgery (ERAS) pathway comprises a set of comprehensive elements which have been reported to enhance patient postoperative prognosis. In the current study, we aimed to evaluate the effectiveness of the ERAS in patients undergoing laparoscopic adrenal resection. A retrospective review was performed to compare the outcomes of patients undergoing adrenalectomy for primary aldosteronism between the pre-ERAS period and the ERAS era. Data was generated from the traditional surgical period (September 1, 2019, to December 31, 2019) and the ERAS period (September 1, 2020, to December 31, 2020), respectively. Forty-seven adrenalectomy patients were enrolled (pre-ERAS, n = 21; ERAS, n = 26) in analysis. The results revealed that both total length of hospital stay and postoperative length of stay decreased in the ERAS period compared with the pre-ERAS period (14.19 ± 4.96 vs 11.27 ± 4.37, p = 0.015; 5.43 ± 1.08 vs 3.31 ± 0.97, p < 0.001). The medical expenses decreased significantly in the ERAS group (p < 0.05). While, the surgery-related complications, including urinary retention, retroperitoneal effusion and gastrointestinal discomfort, possessed no statistical difference. The ERAS pathway was safe and feasible for adrenalectomy in patients with primary aldosteronism. The ERAS could promote patients to quickly recover from the postoperative status to a physiological state, and decrease the length of hospitalization and medical cost after surgery.

Papadimitriou L, Butler J (2017) ‘Fast track’ development and approval process for heart failure therapeutics. Clin Pharmacol Ther 102:184–186CrossRef

Furuhata H, Araki K, Ogawa T, Ikeda M (2017) Effect on completion of clinical pathway for improving clinical indicator: cases of hospital stay mortality rate, and comprehensive-volume ratio. J Med Syst 41:206CrossRef

Ripolles-Melchor J, Ramirez-Rodriguez JM, Casans-Frances R, Aldecoa C, Abad-Motos A, Logrono-Egea M, Garcia-Erce JA, Camps-Cervantes A, Ferrando-Ortola C, Suarez de la Rica A, Cuellar-Martinez A, Marmana-Mezquita S, Abad-Gurumeta A, Calvo-Vecino JM (2019) Association between use of enhanced recovery after surgery protocol and postoperative complications in colorectal surgery: the postoperative outcomes within enhanced recovery after surgery protocol (POWER) study. JAMA Surg 154:725–736CrossRef

Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC (2018) Enhanced recovery decreases pulmonary and cardiac complications after thoracotomy for lung cancer. Ann Thorac Surg 106:272–279CrossRef

Liang X, Ying H, Wang H, Xu H, Liu M, Zhou H, Ge H, Jiang W, Feng L, Liu H, Zhang Y, Mao Z, Li J, Shen B, Liang Y, Cai X (2018) Enhanced recovery care versus traditional care after laparoscopic liver resections: a randomized controlled trial. Surg Endosc 32:2746–2757CrossRef

Altman AD, Helpman L, McGee J, Samouelian V, Auclair MH, Brar H, Nelson GS, European Society of Gynecologic Oncology of Canada’s Communities of Practice in, T Venous (2019) Enhanced recovery after surgery: implementing a new standard of surgical care. CMAJ 191:E469–E475CrossRef

Zennaro MC, Boulkroun S, Fernandes-Rosa FL (2020) Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol 16:578–589CrossRef

Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, Gabetti L, Mengozzi G, Williams TA, Rabbia F, Veglio F, Mulatero P (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69:1811–1820CrossRef

Vaidya A, Mulatero P, Baudrand R, Adler GK (2018) The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev 39:1057–1088CrossRef

10.

Shibata S, Rinehart J, Zhang J, Moeckel G, Castaneda-Bueno M, Stiegler AL, Boggon TJ, Gamba G, Lifton RP (2013) Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia. Cell Metab 18:660–671CrossRef

11.

Savard S, Amar L, Plouin PF, Steichen O (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62:331–336CrossRef

12.

Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW (2008) Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19:88–90CrossRef

13.

Fder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:1889–1916CrossRef

14.

Kondrup J, Rasmussen HH, Hamberg O, Stanga Z (2003) E.W.G. Ad Hoc, nutritional risk screening (NRS 2002):a new method based on an analysis of controlled clinical trials. Clin Nutr 22(2003):321–336CrossRef

15.

Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16:223–237CrossRef

16.

Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6:41–50CrossRef

17.

Li J, Wang Y, Chang X, Han Z (2020) Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): a systematic review and meta-analysis. Eur J Surg Oncol 46:991–998CrossRef

18.

Kastelan D, Knezevic N, Zibar Tomsic K, Alduk AM, Kakarigi L, Kastelan M, Coric M, Skoric-Polovina T, Solak M, Kraljevic I, Balasko A (2020) Open vs laparoscopic adrenalectomy for localized adrenocortical carcinoma. Clin Endocrinol 93(4):404–408CrossRef

19.

Smith MD, McCall J, Plank L, Herbison GP, Soop M, Nygren J (2014) Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009161.pub2CrossRefPubMedPubMedCentral

20.

Webster J, Osborne SR, Gill R, Chow CF, Wallin S, Jones L, Tang A (2014) Does preoperative oral carbohydrate reduce hospital stay? A randomized trial. AORN J 99:233–242CrossRef

21.

Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, Acheson N, Ljungqvist O, Dowdy SC (2016) Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: enhanced recovery after surgery (ERAS(R)) society recommendations–part I. Gynecol Oncol 140:313–322CrossRef

22.

Hawn MT, Richman JS, Vick CC, Deierhoi RJ, Graham LA, Henderson WG, Itani KM (2013) Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 148:649–657CrossRef

23.

Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM (2017) The disinfect initiative: decreasing the incidence of surgical infections in gynecologic oncology. Ann Surg Oncol 24:362–368CrossRef

24.

Madrid E, Urrutia G, Roque M, Figuls I, Pardo-Hernandez H, Campos JM, Paniagua P, Maestre L, Alonso-Coello P (2016) Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009016.pub2CrossRefPubMedPubMedCentral

25.

Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, Christophi C, Leslie K, McGuinness S, Parke R, Serpell J, Chan MTV, Painter T, McCluskey S, Minto G, Wallace S (2018) Australian, N New Zealand College of Anaesthetists Clinical Trials, A the, G New Zealand Intensive Care Society Clinical Trials, restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 378:2263–2274CrossRef

Title: A combination of laparoscopic approach and ERAS pathway optimizes outcomes and cost for adrenalectomy
Authors: Zhiwen He
Siming Chen
Mengxin Lu
Yongwen Luo
Tongzu Liu
Yu Xiao
Xinghuan Wang
Publication date: 01-04-2022
Publisher: Springer International Publishing
Keywords: Adrenalectomy
Adrenalectomy
Published in: Updates in Surgery / Issue 2/2022
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-021-01188-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A combination of laparoscopic approach and ERAS pathway optimizes outcomes and cost for adrenalectomy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2022

Minimally invasive treatment of colorectal liver metastases: does robotic surgery provide any technical advantages over laparoscopy? A multicenter analysis from the IGoMILS (Italian Group of Minimally Invasive Liver Surgery) registry

Influence of incorrect staging of colorectal carcinoma on oncological outcome: are we playing safely?

Natural orifice specimen extraction surgery versus conventional laparoscopic-assisted resection for colorectal cancer in elderly patients: a propensity-score matching study

Clinical epigenetics and restoring of metabolic health in severely obese patients undergoing batriatric and metabolic surgery

Clinical outcomes and functional analysis of third space robotic and endoscopic cooperative surgery versus laparoscopic wedge resection for gastric submucosal tumours: a propensity score-matched study

Bibliometric analysis of metabolic surgery for type 2 diabetes: current status and future prospects